bendamustine hydrochloride has been researched along with valganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawashima, I; Kirito, K; Mitsumori, T; Nakajima, K; Nozaki, Y; Sueki, Y; Yamamoto, T | 1 |
| Ancona, G; Chiamenti, M; Codecà, C; Cona, A; d'Arminio Monforte, A; Ferrari, D; Marchetti, G; Marti, A; Merlini, E; Tesoro, D; Tincati, C | 1 |
1 review(s) available for bendamustine hydrochloride and valganciclovir
| Article | Year |
|---|---|
[Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy].
Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Bendamustine Hydrochloride; Biomarkers; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Opportunistic Infections; Treatment Outcome; Valganciclovir; Virus Activation | 2014 |
1 other study(ies) available for bendamustine hydrochloride and valganciclovir
| Article | Year |
|---|---|
Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets.
Topics: Aged; Antineoplastic Agents, Alkylating; Antiviral Agents; B-Lymphocytes; Bendamustine Hydrochloride; CD8-Positive T-Lymphocytes; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Humans; Male; T-Lymphocyte Subsets; Valganciclovir; Waldenstrom Macroglobulinemia | 2019 |